Laddar...
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Buprenorphine is a partial μ-opioid agonist widely used for opioid maintenance therapy (OMT). It is mainly metabolized to pharmacologically active norbuprenorphine by the cytochrome P450 (CYP) isozyme 3A4. This may give rise to drug–drug interactions under combinations with inhibitors or inducers of...
Sparad:
| I publikationen: | Eur Arch Psychiatry Clin Neurosci |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer Berlin Heidelberg
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8236049/ https://ncbi.nlm.nih.gov/pubmed/31907614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00406-019-01091-0 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|